Substance use touches on many facets of public policy, including health and health care, economic issues, criminal justice, and risk behaviors — particularly among youth. Accordingly, RAND conducts drug policy research that addresses a range of concerns, from treatment effectiveness, harm reduction, drug markets and supply, and predictors and consequences to evaluations of programs to prevent youth from using and abusing drugs, alcohol, and tobacco.
Featured at RAND
The nature of the American drug problem has changed substantially over the last 20 years. It is now less of a crime problem illustrated by drug market violence and more of a health problem with higher rates of morbidity and mortality, and a criminal justice problem of burdensome incarceration rates.
Group MI for Teens provides guidance on facilitating motivational interviewing (MI) interventions to groups of adolescents, helping them make healthy choices regarding alcohol and drug use.
The RAND Drug Policy Research Center (DPRC) helps community leaders and public officials develop more effective ways of dealing with drug problems. DPRC provides a firm, empirical foundation on which sound drug policies can be built.
RAND Europe is conducting an independent evaluation of the Department of Health's drug and alcohol recovery payment-by-results pilots to determine whether market forces can encourage the development of better recovery programmes.
To further analyze Europe's illicit drug market and the EU's responses to it, DPRC and RAND Europe are teaming with European partners to expand their original 2009 research on the global drug market.
The Building Recovery by Improving Goals, Habits, and Thoughts (BRIGHT) project is a collaborative effort to understand how well cognitive behavioral therapy depression treatment works for people with substance use disorder.